Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2024-07-03 00:00:00 ET · period of report 2024-07-01 · accession 0001415889-24-019276 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-07-03 | 2024-07-01 | MIRM | Howe Jolanda | SVP, Gbl Ctrl | M - OptEx | — | +1,042 | 2,801 | +59% | — |
| D | 2024-07-03 | 2024-07-02 | MIRM | Howe Jolanda | SVP, Gbl Ctrl | S - Sale+OE | $34.00 | -375 | 2,426 | -13% | -$12.8K |
| D | 2024-07-03 | 2024-07-01 | MIRM | Howe Jolanda | SVP, Gbl Ctrl | M - OptEx | $0.00 | -1,042 | 1,041 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-01 | M | A | 1,042 | — | 2,801 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). |
| 2 | Common | Common Stock | 2024-07-02 | S | D | 375 | $34.00 | 2,426 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2024-07-01 | M | D | 1,042 | $0.00 | 1,041 | D | — · — to — | 1,042 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). (F3) The restricted stock units vest in a series of three successive equal annual installments beginning July 1, 2023. |